Talking to the Lords
Gay men’s PrEP study final results: near 90% efficacy in men who took drug, but adherence even lower than thought
New NNRTI lersivirine matches efavirenz in phase 2 study
Revolutionary and luminary
HIV vaccine technologists edge nearer to effective designs
Spanish steps